Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

NYSE:CNK - New York Stock Exchange, Inc. - US17243V1026 - Common Stock - Currency: USD

30.71  +0.53 (+1.76%)

After market: 30.71 0 (0%)

Fundamental Rating

5

CNK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. CNK scores excellent on profitability, but there are concerns on its financial health. CNK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
In the past year CNK had a positive cash flow from operations.
In multiple years CNK reported negative net income over the last 5 years.
Of the past 5 years CNK 4 years had a positive operating cash flow.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

The Return On Assets of CNK (5.16%) is better than 83.33% of its industry peers.
With an excellent Return On Equity value of 69.13%, CNK belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.83%, CNK belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CNK is significantly below the industry average of 22.90%.
The last Return On Invested Capital (7.83%) for CNK is above the 3 year average (5.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROIC 7.83%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

CNK's Profit Margin of 8.02% is amongst the best of the industry. CNK outperforms 84.72% of its industry peers.
CNK's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 10.66%, CNK belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
CNK's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 64.38%, CNK is doing good in the industry, outperforming 73.61% of the companies in the same industry.
In the last couple of years the Gross Margin of CNK has remained more or less at the same level.
Industry RankSector Rank
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNK is still creating some value.
CNK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CNK has been increased compared to 5 years ago.
Compared to 1 year ago, CNK has an improved debt to assets ratio.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that CNK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.23, CNK is in line with its industry, outperforming 48.61% of the companies in the same industry.
CNK has a debt to FCF ratio of 11.16. This is a negative value and a sign of low solvency as CNK would need 11.16 years to pay back of all of its debts.
CNK's Debt to FCF ratio of 11.16 is in line compared to the rest of the industry. CNK outperforms 58.33% of its industry peers.
CNK has a Debt/Equity ratio of 5.66. This is a high value indicating a heavy dependency on external financing.
CNK has a worse Debt to Equity ratio (5.66) than 76.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Altman-Z 1.23
ROIC/WACC1.07
WACC7.33%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.79 indicates that CNK may have some problems paying its short term obligations.
The Current ratio of CNK (0.79) is comparable to the rest of the industry.
CNK has a Quick Ratio of 0.79. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
CNK has a Quick ratio of 0.76. This is comparable to the rest of the industry: CNK outperforms 41.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.76
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.83% over the past year.
Measured over the past 5 years, CNK shows a small growth in Earnings Per Share. The EPS has been growing by 4.49% on average per year.
CNK shows a decrease in Revenue. In the last year, the revenue decreased by -0.80%.
The Revenue has been decreasing by -1.47% on average over the past years.
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%

3.2 Future

The Earnings Per Share is expected to grow by 9.85% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.68% on average over the next years.
EPS Next Y-13.93%
EPS Next 2Y7.46%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.20 indicates a rather expensive valuation of CNK.
CNK's Price/Earnings ratio is rather cheap when compared to the industry. CNK is cheaper than 84.72% of the companies in the same industry.
CNK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.45.
The Price/Forward Earnings ratio is 13.10, which indicates a correct valuation of CNK.
90.28% of the companies in the same industry are more expensive than CNK, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CNK to the average of the S&P500 Index (21.90), we can say CNK is valued slightly cheaper.
Industry RankSector Rank
PE 20.2
Fwd PE 13.1
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNK is valued cheaper than 80.56% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CNK is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.04
EV/EBITDA 10.2
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of CNK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.5
EPS Next 2Y7.46%
EPS Next 3Y9.85%

3

5. Dividend

5.1 Amount

CNK has a yearly dividend return of 0.53%, which is pretty low.
CNK's Dividend Yield is rather good when compared to the industry average which is at 6.64. CNK pays more dividend than 81.94% of the companies in the same industry.
With a Dividend Yield of 0.53, CNK pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

CNK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y7.46%
EPS Next 3Y9.85%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (7/3/2025, 7:13:23 PM)

After market: 30.71 0 (0%)

30.71

+0.53 (+1.76%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners122.04%
Inst Owner Change-2.85%
Ins Owners2.11%
Ins Owner Change-5.79%
Market Cap3.53B
Analysts75
Price Target33.94 (10.52%)
Short Float %24.9%
Short Ratio6.48
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date05-29 2025-05-29 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.93%
Min EPS beat(2)-100.53%
Max EPS beat(2)-13.33%
EPS beat(4)2
Avg EPS beat(4)62.52%
Min EPS beat(4)-100.53%
Max EPS beat(4)254.24%
EPS beat(8)5
Avg EPS beat(8)64.97%
EPS beat(12)6
Avg EPS beat(12)-8.2%
EPS beat(16)7
Avg EPS beat(16)1.09%
Revenue beat(2)1
Avg Revenue beat(2)0.74%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)2.45%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)5.09%
Revenue beat(8)7
Avg Revenue beat(8)2.96%
Revenue beat(12)10
Avg Revenue beat(12)2.73%
Revenue beat(16)13
Avg Revenue beat(16)6.14%
PT rev (1m)1.44%
PT rev (3m)2.2%
EPS NQ rev (1m)3.65%
EPS NQ rev (3m)18.49%
EPS NY rev (1m)4.99%
EPS NY rev (3m)-2.65%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)4.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 20.2
Fwd PE 13.1
P/S 1.17
P/FCF 16.04
P/OCF 9.56
P/B 10.11
P/tB N/A
EV/EBITDA 10.2
EPS(TTM)1.52
EY4.95%
EPS(NY)2.34
Fwd EY7.63%
FCF(TTM)1.91
FCFY6.23%
OCF(TTM)3.21
OCFY10.46%
SpS26.18
BVpS3.04
TBVpS-10.38
PEG (NY)N/A
PEG (5Y)4.5
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROCE 9.05%
ROIC 7.83%
ROICexc 9.75%
ROICexgc 21.27%
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
FCFM 7.31%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Debt/EBITDA 3.81
Cap/Depr 75.61%
Cap/Sales 4.96%
Interest Coverage 2.19
Cash Conversion 71.26%
Profit Quality 91.22%
Current Ratio 0.79
Quick Ratio 0.76
Altman-Z 1.23
F-Score6
WACC7.33%
ROIC/WACC1.07
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
EPS Next Y-13.93%
EPS Next 2Y7.46%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A
EBIT growth 1Y-10.88%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year81.21%
EBIT Next 3Y29.04%
EBIT Next 5YN/A
FCF growth 1Y52.49%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y40.69%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%